nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisolone—SLCO1A2—Chlorambucil—testicular cancer	0.349	0.433	CbGbCtD
Prednisolone—CYP2A6—Ifosfamide—testicular cancer	0.16	0.199	CbGbCtD
Prednisolone—SLCO1A2—Methotrexate—testicular cancer	0.0625	0.0775	CbGbCtD
Prednisolone—ABCB1—Dactinomycin—testicular cancer	0.0453	0.0562	CbGbCtD
Prednisolone—CYP3A4—Ifosfamide—testicular cancer	0.0321	0.0398	CbGbCtD
Prednisolone—ABCB1—Vinblastine—testicular cancer	0.0284	0.0352	CbGbCtD
Prednisolone—ABCB1—Cisplatin—testicular cancer	0.026	0.0323	CbGbCtD
Prednisolone—ABCB1—Etoposide—testicular cancer	0.0256	0.0317	CbGbCtD
Prednisolone—ABCB1—Doxorubicin—testicular cancer	0.0174	0.0216	CbGbCtD
Prednisolone—CYP3A4—Vinblastine—testicular cancer	0.017	0.0211	CbGbCtD
Prednisolone—ABCB1—Methotrexate—testicular cancer	0.0169	0.021	CbGbCtD
Prednisolone—CYP3A4—Etoposide—testicular cancer	0.0153	0.019	CbGbCtD
Prednisolone—CYP3A4—Doxorubicin—testicular cancer	0.0105	0.013	CbGbCtD
Prednisolone—Vasculitis—Methotrexate—testicular cancer	0.000544	0.00281	CcSEcCtD
Prednisolone—Visual impairment—Ifosfamide—testicular cancer	0.000543	0.00281	CcSEcCtD
Prednisolone—Sweating increased—Etoposide—testicular cancer	0.000542	0.0028	CcSEcCtD
Prednisolone—Herpes simplex—Epirubicin—testicular cancer	0.000539	0.00279	CcSEcCtD
Prednisolone—Erythema—Dactinomycin—testicular cancer	0.000536	0.00277	CcSEcCtD
Prednisolone—Acute coronary syndrome—Cisplatin—testicular cancer	0.000534	0.00276	CcSEcCtD
Prednisolone—Ill-defined disorder—Bleomycin—testicular cancer	0.000533	0.00275	CcSEcCtD
Prednisolone—Myocardial infarction—Cisplatin—testicular cancer	0.000531	0.00274	CcSEcCtD
Prednisolone—Neuropathy peripheral—Cisplatin—testicular cancer	0.000531	0.00274	CcSEcCtD
Prednisolone—Conjunctivitis—Cisplatin—testicular cancer	0.000526	0.00272	CcSEcCtD
Prednisolone—Malaise—Bleomycin—testicular cancer	0.000518	0.00268	CcSEcCtD
Prednisolone—Pain—Chlorambucil—testicular cancer	0.000518	0.00268	CcSEcCtD
Prednisolone—Viral infection—Doxorubicin—testicular cancer	0.000509	0.00263	CcSEcCtD
Prednisolone—Arthropathy—Doxorubicin—testicular cancer	0.000506	0.00261	CcSEcCtD
Prednisolone—Arrhythmia—Ifosfamide—testicular cancer	0.000504	0.0026	CcSEcCtD
Prednisolone—Herpes simplex—Doxorubicin—testicular cancer	0.000499	0.00258	CcSEcCtD
Prednisolone—Feeling abnormal—Chlorambucil—testicular cancer	0.000499	0.00258	CcSEcCtD
Prednisolone—Paraesthesia—Vinblastine—testicular cancer	0.000498	0.00257	CcSEcCtD
Prednisolone—Hiccups—Epirubicin—testicular cancer	0.000497	0.00257	CcSEcCtD
Prednisolone—Ill-defined disorder—Dactinomycin—testicular cancer	0.000497	0.00257	CcSEcCtD
Prednisolone—Bradycardia—Cisplatin—testicular cancer	0.000495	0.00256	CcSEcCtD
Prednisolone—Erythema—Ifosfamide—testicular cancer	0.000491	0.00254	CcSEcCtD
Prednisolone—Acute coronary syndrome—Etoposide—testicular cancer	0.000489	0.00253	CcSEcCtD
Prednisolone—Myocardial infarction—Etoposide—testicular cancer	0.000486	0.00251	CcSEcCtD
Prednisolone—Neuropathy peripheral—Etoposide—testicular cancer	0.000486	0.00251	CcSEcCtD
Prednisolone—Discomfort—Bleomycin—testicular cancer	0.000483	0.0025	CcSEcCtD
Prednisolone—Malaise—Dactinomycin—testicular cancer	0.000483	0.00249	CcSEcCtD
Prednisolone—Urticaria—Chlorambucil—testicular cancer	0.000481	0.00249	CcSEcCtD
Prednisolone—Ecchymosis—Methotrexate—testicular cancer	0.00048	0.00248	CcSEcCtD
Prednisolone—Pain—Vinblastine—testicular cancer	0.000475	0.00245	CcSEcCtD
Prednisolone—Pulmonary oedema—Methotrexate—testicular cancer	0.000473	0.00244	CcSEcCtD
Prednisolone—Fluid retention—Epirubicin—testicular cancer	0.000472	0.00244	CcSEcCtD
Prednisolone—Oedema—Bleomycin—testicular cancer	0.000469	0.00242	CcSEcCtD
Prednisolone—Anaphylactic shock—Bleomycin—testicular cancer	0.000469	0.00242	CcSEcCtD
Prednisolone—Visual impairment—Cisplatin—testicular cancer	0.000468	0.00242	CcSEcCtD
Prednisolone—Neuropathy—Epirubicin—testicular cancer	0.000467	0.00241	CcSEcCtD
Prednisolone—Vision blurred—Ifosfamide—testicular cancer	0.000463	0.00239	CcSEcCtD
Prednisolone—Hiccups—Doxorubicin—testicular cancer	0.00046	0.00238	CcSEcCtD
Prednisolone—Feeling abnormal—Vinblastine—testicular cancer	0.000457	0.00236	CcSEcCtD
Prednisolone—Ill-defined disorder—Ifosfamide—testicular cancer	0.000455	0.00235	CcSEcCtD
Prednisolone—Discomfort—Dactinomycin—testicular cancer	0.000451	0.00233	CcSEcCtD
Prednisolone—Ecchymosis—Epirubicin—testicular cancer	0.000449	0.00232	CcSEcCtD
Prednisolone—Angioedema—Ifosfamide—testicular cancer	0.000448	0.00232	CcSEcCtD
Prednisolone—Hypersensitivity—Chlorambucil—testicular cancer	0.000446	0.0023	CcSEcCtD
Prednisolone—Thrombophlebitis—Methotrexate—testicular cancer	0.000445	0.0023	CcSEcCtD
Prednisolone—Diabetes mellitus—Methotrexate—testicular cancer	0.000443	0.00229	CcSEcCtD
Prednisolone—Malaise—Ifosfamide—testicular cancer	0.000443	0.00229	CcSEcCtD
Prednisolone—Pulmonary oedema—Epirubicin—testicular cancer	0.000442	0.00229	CcSEcCtD
Prednisolone—Vertigo—Ifosfamide—testicular cancer	0.000441	0.00228	CcSEcCtD
Prednisolone—Oedema—Dactinomycin—testicular cancer	0.000437	0.00226	CcSEcCtD
Prednisolone—Fluid retention—Doxorubicin—testicular cancer	0.000437	0.00226	CcSEcCtD
Prednisolone—Arrhythmia—Cisplatin—testicular cancer	0.000434	0.00224	CcSEcCtD
Prednisolone—Neuropathy—Doxorubicin—testicular cancer	0.000432	0.00223	CcSEcCtD
Prednisolone—Convulsion—Ifosfamide—testicular cancer	0.000425	0.0022	CcSEcCtD
Prednisolone—Hypertension—Ifosfamide—testicular cancer	0.000424	0.00219	CcSEcCtD
Prednisolone—Erythema—Cisplatin—testicular cancer	0.000423	0.00219	CcSEcCtD
Prednisolone—Paraesthesia—Bleomycin—testicular cancer	0.000421	0.00217	CcSEcCtD
Prednisolone—Thrombophlebitis—Epirubicin—testicular cancer	0.000417	0.00215	CcSEcCtD
Prednisolone—Ecchymosis—Doxorubicin—testicular cancer	0.000416	0.00215	CcSEcCtD
Prednisolone—Diabetes mellitus—Epirubicin—testicular cancer	0.000415	0.00214	CcSEcCtD
Prednisolone—Discomfort—Ifosfamide—testicular cancer	0.000413	0.00213	CcSEcCtD
Prednisolone—Pulmonary oedema—Doxorubicin—testicular cancer	0.000409	0.00211	CcSEcCtD
Prednisolone—Hypersensitivity—Vinblastine—testicular cancer	0.000409	0.00211	CcSEcCtD
Prednisolone—Visual disturbance—Methotrexate—testicular cancer	0.000407	0.0021	CcSEcCtD
Prednisolone—Pain—Bleomycin—testicular cancer	0.000401	0.00207	CcSEcCtD
Prednisolone—Anaphylactic shock—Ifosfamide—testicular cancer	0.000401	0.00207	CcSEcCtD
Prednisolone—Oedema—Ifosfamide—testicular cancer	0.000401	0.00207	CcSEcCtD
Prednisolone—Vision blurred—Cisplatin—testicular cancer	0.000399	0.00206	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Methotrexate—testicular cancer	0.000398	0.00206	CcSEcCtD
Prednisolone—Cardiac failure congestive—Epirubicin—testicular cancer	0.000398	0.00206	CcSEcCtD
Prednisolone—Ill-defined disorder—Cisplatin—testicular cancer	0.000393	0.00203	CcSEcCtD
Prednisolone—Hyperhidrosis—Ifosfamide—testicular cancer	0.000387	0.002	CcSEcCtD
Prednisolone—Feeling abnormal—Bleomycin—testicular cancer	0.000386	0.002	CcSEcCtD
Prednisolone—Thrombophlebitis—Doxorubicin—testicular cancer	0.000386	0.00199	CcSEcCtD
Prednisolone—Osteoarthritis—Methotrexate—testicular cancer	0.000386	0.00199	CcSEcCtD
Prednisolone—Increased appetite—Epirubicin—testicular cancer	0.000384	0.00198	CcSEcCtD
Prednisolone—Diabetes mellitus—Doxorubicin—testicular cancer	0.000384	0.00198	CcSEcCtD
Prednisolone—Malaise—Cisplatin—testicular cancer	0.000382	0.00197	CcSEcCtD
Prednisolone—Dermatitis bullous—Epirubicin—testicular cancer	0.000378	0.00195	CcSEcCtD
Prednisolone—Pain—Dactinomycin—testicular cancer	0.000374	0.00193	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Epirubicin—testicular cancer	0.000373	0.00193	CcSEcCtD
Prednisolone—Urticaria—Bleomycin—testicular cancer	0.000372	0.00192	CcSEcCtD
Prednisolone—Cardiac failure congestive—Doxorubicin—testicular cancer	0.000368	0.0019	CcSEcCtD
Prednisolone—Dizziness—Vinblastine—testicular cancer	0.000367	0.0019	CcSEcCtD
Prednisolone—Convulsion—Cisplatin—testicular cancer	0.000367	0.00189	CcSEcCtD
Prednisolone—Mood swings—Methotrexate—testicular cancer	0.000365	0.00189	CcSEcCtD
Prednisolone—Osteoarthritis—Epirubicin—testicular cancer	0.000361	0.00186	CcSEcCtD
Prednisolone—Feeling abnormal—Dactinomycin—testicular cancer	0.00036	0.00186	CcSEcCtD
Prednisolone—Nausea—Chlorambucil—testicular cancer	0.00036	0.00186	CcSEcCtD
Prednisolone—Paraesthesia—Ifosfamide—testicular cancer	0.00036	0.00186	CcSEcCtD
Prednisolone—Ill-defined disorder—Etoposide—testicular cancer	0.00036	0.00186	CcSEcCtD
Prednisolone—Discomfort—Cisplatin—testicular cancer	0.000356	0.00184	CcSEcCtD
Prednisolone—Increased appetite—Doxorubicin—testicular cancer	0.000355	0.00184	CcSEcCtD
Prednisolone—Affect lability—Epirubicin—testicular cancer	0.000355	0.00183	CcSEcCtD
Prednisolone—Malaise—Etoposide—testicular cancer	0.00035	0.00181	CcSEcCtD
Prednisolone—Dermatitis bullous—Doxorubicin—testicular cancer	0.000349	0.0018	CcSEcCtD
Prednisolone—Vertigo—Etoposide—testicular cancer	0.000348	0.0018	CcSEcCtD
Prednisolone—Headache—Vinblastine—testicular cancer	0.000348	0.0018	CcSEcCtD
Prednisolone—Oedema—Cisplatin—testicular cancer	0.000345	0.00178	CcSEcCtD
Prednisolone—Anaphylactic shock—Cisplatin—testicular cancer	0.000345	0.00178	CcSEcCtD
Prednisolone—Hypersensitivity—Bleomycin—testicular cancer	0.000345	0.00178	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.000345	0.00178	CcSEcCtD
Prednisolone—Cardiac arrest—Epirubicin—testicular cancer	0.000343	0.00177	CcSEcCtD
Prednisolone—Pain—Ifosfamide—testicular cancer	0.000343	0.00177	CcSEcCtD
Prednisolone—Mood swings—Epirubicin—testicular cancer	0.000342	0.00177	CcSEcCtD
Prednisolone—Loss of consciousness—Etoposide—testicular cancer	0.000341	0.00176	CcSEcCtD
Prednisolone—Tachycardia—Cisplatin—testicular cancer	0.000337	0.00174	CcSEcCtD
Prednisolone—Convulsion—Etoposide—testicular cancer	0.000336	0.00173	CcSEcCtD
Prednisolone—Hypertension—Etoposide—testicular cancer	0.000335	0.00173	CcSEcCtD
Prednisolone—Osteoarthritis—Doxorubicin—testicular cancer	0.000334	0.00172	CcSEcCtD
Prednisolone—Hyperhidrosis—Cisplatin—testicular cancer	0.000334	0.00172	CcSEcCtD
Prednisolone—Dry skin—Epirubicin—testicular cancer	0.000331	0.00171	CcSEcCtD
Prednisolone—Feeling abnormal—Ifosfamide—testicular cancer	0.00033	0.00171	CcSEcCtD
Prednisolone—Nausea—Vinblastine—testicular cancer	0.00033	0.0017	CcSEcCtD
Prednisolone—Affect lability—Doxorubicin—testicular cancer	0.000329	0.0017	CcSEcCtD
Prednisolone—Pancreatitis—Methotrexate—testicular cancer	0.000327	0.00169	CcSEcCtD
Prednisolone—Discomfort—Etoposide—testicular cancer	0.000326	0.00168	CcSEcCtD
Prednisolone—Hypersensitivity—Dactinomycin—testicular cancer	0.000322	0.00166	CcSEcCtD
Prednisolone—Muscular weakness—Epirubicin—testicular cancer	0.000318	0.00164	CcSEcCtD
Prednisolone—Urticaria—Ifosfamide—testicular cancer	0.000318	0.00164	CcSEcCtD
Prednisolone—Cardiac arrest—Doxorubicin—testicular cancer	0.000317	0.00164	CcSEcCtD
Prednisolone—Anaphylactic shock—Etoposide—testicular cancer	0.000316	0.00163	CcSEcCtD
Prednisolone—Mood swings—Doxorubicin—testicular cancer	0.000316	0.00163	CcSEcCtD
Prednisolone—Abdominal distension—Epirubicin—testicular cancer	0.000314	0.00162	CcSEcCtD
Prednisolone—Paraesthesia—Cisplatin—testicular cancer	0.00031	0.0016	CcSEcCtD
Prednisolone—Tachycardia—Etoposide—testicular cancer	0.000309	0.00159	CcSEcCtD
Prednisolone—Dry skin—Doxorubicin—testicular cancer	0.000306	0.00158	CcSEcCtD
Prednisolone—Hyperhidrosis—Etoposide—testicular cancer	0.000306	0.00158	CcSEcCtD
Prednisolone—Pancreatitis—Epirubicin—testicular cancer	0.000306	0.00158	CcSEcCtD
Prednisolone—Rash—Bleomycin—testicular cancer	0.000296	0.00153	CcSEcCtD
Prednisolone—Pain—Cisplatin—testicular cancer	0.000295	0.00153	CcSEcCtD
Prednisolone—Dermatitis—Bleomycin—testicular cancer	0.000295	0.00153	CcSEcCtD
Prednisolone—Hypersensitivity—Ifosfamide—testicular cancer	0.000295	0.00152	CcSEcCtD
Prednisolone—Muscular weakness—Doxorubicin—testicular cancer	0.000294	0.00152	CcSEcCtD
Prednisolone—Abdominal distension—Doxorubicin—testicular cancer	0.000291	0.0015	CcSEcCtD
Prednisolone—Conjunctivitis—Methotrexate—testicular cancer	0.000289	0.00149	CcSEcCtD
Prednisolone—Feeling abnormal—Cisplatin—testicular cancer	0.000285	0.00147	CcSEcCtD
Prednisolone—Paraesthesia—Etoposide—testicular cancer	0.000284	0.00147	CcSEcCtD
Prednisolone—Weight increased—Epirubicin—testicular cancer	0.000284	0.00147	CcSEcCtD
Prednisolone—Pancreatitis—Doxorubicin—testicular cancer	0.000283	0.00146	CcSEcCtD
Prednisolone—Nausea—Bleomycin—testicular cancer	0.000278	0.00144	CcSEcCtD
Prednisolone—Rash—Dactinomycin—testicular cancer	0.000276	0.00142	CcSEcCtD
Prednisolone—Neuropathy peripheral—Epirubicin—testicular cancer	0.000273	0.00141	CcSEcCtD
Prednisolone—Pain—Etoposide—testicular cancer	0.000271	0.0014	CcSEcCtD
Prednisolone—Conjunctivitis—Epirubicin—testicular cancer	0.00027	0.0014	CcSEcCtD
Prednisolone—Haemoglobin—Methotrexate—testicular cancer	0.000268	0.00138	CcSEcCtD
Prednisolone—Haemorrhage—Methotrexate—testicular cancer	0.000267	0.00138	CcSEcCtD
Prednisolone—Dizziness—Ifosfamide—testicular cancer	0.000265	0.00137	CcSEcCtD
Prednisolone—Weight increased—Doxorubicin—testicular cancer	0.000263	0.00136	CcSEcCtD
Prednisolone—Feeling abnormal—Etoposide—testicular cancer	0.000261	0.00135	CcSEcCtD
Prednisolone—Nausea—Dactinomycin—testicular cancer	0.00026	0.00134	CcSEcCtD
Prednisolone—Visual impairment—Methotrexate—testicular cancer	0.000257	0.00133	CcSEcCtD
Prednisolone—Hypersensitivity—Cisplatin—testicular cancer	0.000254	0.00131	CcSEcCtD
Prednisolone—Bradycardia—Epirubicin—testicular cancer	0.000254	0.00131	CcSEcCtD
Prednisolone—Rash—Ifosfamide—testicular cancer	0.000253	0.0013	CcSEcCtD
Prednisolone—Dermatitis—Ifosfamide—testicular cancer	0.000252	0.0013	CcSEcCtD
Prednisolone—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000252	0.0013	CcSEcCtD
Prednisolone—Urticaria—Etoposide—testicular cancer	0.000251	0.0013	CcSEcCtD
Prednisolone—Haemoglobin—Epirubicin—testicular cancer	0.000251	0.0013	CcSEcCtD
Prednisolone—Conjunctivitis—Doxorubicin—testicular cancer	0.00025	0.00129	CcSEcCtD
Prednisolone—Haemorrhage—Epirubicin—testicular cancer	0.00025	0.00129	CcSEcCtD
Prednisolone—Visual impairment—Epirubicin—testicular cancer	0.000241	0.00124	CcSEcCtD
Prednisolone—Nausea—Ifosfamide—testicular cancer	0.000238	0.00123	CcSEcCtD
Prednisolone—Bradycardia—Doxorubicin—testicular cancer	0.000235	0.00121	CcSEcCtD
Prednisolone—Hypersensitivity—Etoposide—testicular cancer	0.000233	0.0012	CcSEcCtD
Prednisolone—Erythema—Methotrexate—testicular cancer	0.000232	0.0012	CcSEcCtD
Prednisolone—Haemoglobin—Doxorubicin—testicular cancer	0.000232	0.0012	CcSEcCtD
Prednisolone—Haemorrhage—Doxorubicin—testicular cancer	0.000231	0.00119	CcSEcCtD
Prednisolone—Arrhythmia—Epirubicin—testicular cancer	0.000223	0.00115	CcSEcCtD
Prednisolone—Visual impairment—Doxorubicin—testicular cancer	0.000223	0.00115	CcSEcCtD
Prednisolone—Vision blurred—Methotrexate—testicular cancer	0.000219	0.00113	CcSEcCtD
Prednisolone—Rash—Cisplatin—testicular cancer	0.000218	0.00112	CcSEcCtD
Prednisolone—Dermatitis—Cisplatin—testicular cancer	0.000218	0.00112	CcSEcCtD
Prednisolone—Erythema—Epirubicin—testicular cancer	0.000217	0.00112	CcSEcCtD
Prednisolone—Ill-defined disorder—Methotrexate—testicular cancer	0.000215	0.00111	CcSEcCtD
Prednisolone—Malaise—Methotrexate—testicular cancer	0.000209	0.00108	CcSEcCtD
Prednisolone—Dizziness—Etoposide—testicular cancer	0.000209	0.00108	CcSEcCtD
Prednisolone—Vertigo—Methotrexate—testicular cancer	0.000209	0.00108	CcSEcCtD
Prednisolone—Arrhythmia—Doxorubicin—testicular cancer	0.000206	0.00107	CcSEcCtD
Prednisolone—Nausea—Cisplatin—testicular cancer	0.000205	0.00106	CcSEcCtD
Prednisolone—Vision blurred—Epirubicin—testicular cancer	0.000205	0.00106	CcSEcCtD
Prednisolone—Ill-defined disorder—Epirubicin—testicular cancer	0.000202	0.00104	CcSEcCtD
Prednisolone—Convulsion—Methotrexate—testicular cancer	0.000201	0.00104	CcSEcCtD
Prednisolone—Erythema—Doxorubicin—testicular cancer	0.000201	0.00104	CcSEcCtD
Prednisolone—Rash—Etoposide—testicular cancer	0.000199	0.00103	CcSEcCtD
Prednisolone—Dermatitis—Etoposide—testicular cancer	0.000199	0.00103	CcSEcCtD
Prednisolone—Headache—Etoposide—testicular cancer	0.000198	0.00102	CcSEcCtD
Prednisolone—Malaise—Epirubicin—testicular cancer	0.000196	0.00101	CcSEcCtD
Prednisolone—Discomfort—Methotrexate—testicular cancer	0.000195	0.00101	CcSEcCtD
Prednisolone—Vertigo—Epirubicin—testicular cancer	0.000195	0.00101	CcSEcCtD
Prednisolone—Syncope—Epirubicin—testicular cancer	0.000195	0.00101	CcSEcCtD
Prednisolone—Loss of consciousness—Epirubicin—testicular cancer	0.000191	0.000987	CcSEcCtD
Prednisolone—Anaphylactic shock—Methotrexate—testicular cancer	0.00019	0.000979	CcSEcCtD
Prednisolone—Vision blurred—Doxorubicin—testicular cancer	0.000189	0.000979	CcSEcCtD
Prednisolone—Convulsion—Epirubicin—testicular cancer	0.000188	0.000973	CcSEcCtD
Prednisolone—Nausea—Etoposide—testicular cancer	0.000188	0.000971	CcSEcCtD
Prednisolone—Hypertension—Epirubicin—testicular cancer	0.000188	0.000969	CcSEcCtD
Prednisolone—Ill-defined disorder—Doxorubicin—testicular cancer	0.000187	0.000964	CcSEcCtD
Prednisolone—Hyperhidrosis—Methotrexate—testicular cancer	0.000183	0.000946	CcSEcCtD
Prednisolone—Discomfort—Epirubicin—testicular cancer	0.000183	0.000944	CcSEcCtD
Prednisolone—Malaise—Doxorubicin—testicular cancer	0.000181	0.000937	CcSEcCtD
Prednisolone—Vertigo—Doxorubicin—testicular cancer	0.000181	0.000933	CcSEcCtD
Prednisolone—Syncope—Doxorubicin—testicular cancer	0.00018	0.000931	CcSEcCtD
Prednisolone—Oedema—Epirubicin—testicular cancer	0.000177	0.000916	CcSEcCtD
Prednisolone—Anaphylactic shock—Epirubicin—testicular cancer	0.000177	0.000916	CcSEcCtD
Prednisolone—Loss of consciousness—Doxorubicin—testicular cancer	0.000177	0.000913	CcSEcCtD
Prednisolone—Shock—Epirubicin—testicular cancer	0.000174	0.000901	CcSEcCtD
Prednisolone—Convulsion—Doxorubicin—testicular cancer	0.000174	0.0009	CcSEcCtD
Prednisolone—Hypertension—Doxorubicin—testicular cancer	0.000174	0.000897	CcSEcCtD
Prednisolone—Tachycardia—Epirubicin—testicular cancer	0.000173	0.000894	CcSEcCtD
Prednisolone—Hyperhidrosis—Epirubicin—testicular cancer	0.000171	0.000886	CcSEcCtD
Prednisolone—Insomnia—Methotrexate—testicular cancer	0.000171	0.000885	CcSEcCtD
Prednisolone—Paraesthesia—Methotrexate—testicular cancer	0.00017	0.000879	CcSEcCtD
Prednisolone—Discomfort—Doxorubicin—testicular cancer	0.000169	0.000874	CcSEcCtD
Prednisolone—Anaphylactic shock—Doxorubicin—testicular cancer	0.000164	0.000848	CcSEcCtD
Prednisolone—Oedema—Doxorubicin—testicular cancer	0.000164	0.000848	CcSEcCtD
Prednisolone—Pain—Methotrexate—testicular cancer	0.000162	0.000837	CcSEcCtD
Prednisolone—Shock—Doxorubicin—testicular cancer	0.000161	0.000834	CcSEcCtD
Prednisolone—Insomnia—Epirubicin—testicular cancer	0.00016	0.000829	CcSEcCtD
Prednisolone—Tachycardia—Doxorubicin—testicular cancer	0.00016	0.000827	CcSEcCtD
Prednisolone—Paraesthesia—Epirubicin—testicular cancer	0.000159	0.000823	CcSEcCtD
Prednisolone—Hyperhidrosis—Doxorubicin—testicular cancer	0.000159	0.000819	CcSEcCtD
Prednisolone—Feeling abnormal—Methotrexate—testicular cancer	0.000156	0.000807	CcSEcCtD
Prednisolone—Pain—Epirubicin—testicular cancer	0.000152	0.000783	CcSEcCtD
Prednisolone—Urticaria—Methotrexate—testicular cancer	0.000151	0.000778	CcSEcCtD
Prednisolone—Insomnia—Doxorubicin—testicular cancer	0.000148	0.000767	CcSEcCtD
Prednisolone—Paraesthesia—Doxorubicin—testicular cancer	0.000147	0.000761	CcSEcCtD
Prednisolone—Feeling abnormal—Epirubicin—testicular cancer	0.000146	0.000755	CcSEcCtD
Prednisolone—Urticaria—Epirubicin—testicular cancer	0.000141	0.000728	CcSEcCtD
Prednisolone—Pain—Doxorubicin—testicular cancer	0.00014	0.000725	CcSEcCtD
Prednisolone—Hypersensitivity—Methotrexate—testicular cancer	0.00014	0.000721	CcSEcCtD
Prednisolone—Feeling abnormal—Doxorubicin—testicular cancer	0.000135	0.000698	CcSEcCtD
Prednisolone—Hypersensitivity—Epirubicin—testicular cancer	0.000131	0.000675	CcSEcCtD
Prednisolone—Urticaria—Doxorubicin—testicular cancer	0.00013	0.000673	CcSEcCtD
Prednisolone—Dizziness—Methotrexate—testicular cancer	0.000125	0.000647	CcSEcCtD
Prednisolone—Hypersensitivity—Doxorubicin—testicular cancer	0.000121	0.000624	CcSEcCtD
Prednisolone—Rash—Methotrexate—testicular cancer	0.000119	0.000617	CcSEcCtD
Prednisolone—Dermatitis—Methotrexate—testicular cancer	0.000119	0.000617	CcSEcCtD
Prednisolone—Headache—Methotrexate—testicular cancer	0.000119	0.000613	CcSEcCtD
Prednisolone—Dizziness—Epirubicin—testicular cancer	0.000117	0.000606	CcSEcCtD
Prednisolone—Nausea—Methotrexate—testicular cancer	0.000113	0.000581	CcSEcCtD
Prednisolone—Rash—Epirubicin—testicular cancer	0.000112	0.000578	CcSEcCtD
Prednisolone—Dermatitis—Epirubicin—testicular cancer	0.000112	0.000577	CcSEcCtD
Prednisolone—Headache—Epirubicin—testicular cancer	0.000111	0.000574	CcSEcCtD
Prednisolone—Dizziness—Doxorubicin—testicular cancer	0.000109	0.000561	CcSEcCtD
Prednisolone—Nausea—Epirubicin—testicular cancer	0.000105	0.000544	CcSEcCtD
Prednisolone—Rash—Doxorubicin—testicular cancer	0.000103	0.000534	CcSEcCtD
Prednisolone—Dermatitis—Doxorubicin—testicular cancer	0.000103	0.000534	CcSEcCtD
Prednisolone—Headache—Doxorubicin—testicular cancer	0.000103	0.000531	CcSEcCtD
Prednisolone—Nausea—Doxorubicin—testicular cancer	9.75e-05	0.000503	CcSEcCtD
